As we intend to include preferably all available studies that meet the inclusion criteria, and new studies are coming up constantly, the Study Group is constantly gaining new members. If you have conducted a large study or clinical trial where IMT progression and clinical endpoints were assessed, your data may be very valuable for our project. A brief note to our coordinating center with contact details of a study representative will be most appreciated. We are looking forward to our future cooperation.
On behalf of the PROG-IMT Study Group,
Matthias Lorenz, Principal Investigator